Eyenovia Income Statement 2025-2011 | EYEN

Brief overview of revenue and earnings at Eyenovia

The conclusions below are based on five years of reported results. Revenue at Eyenovia moved from 2 million dollars in 2020 to 813 thousand dollars in 2025. The total change was −59.3%, with a CAGR of approximately −16.5%. The negative rate indicates weakening core operations.

Gross profit was 1.2 million dollars at the start and 510 thousand dollars at the end of the period (−57.5%). Direct costs broadly followed the top-line trend. The gross margin was 60% at the start and 62.7% at the end. The expansion indicates stronger pricing power or better control of direct costs.

EBITDA was −$19.7 million at the beginning and −$46.7 million at the end of the period (−137.4%). The operating result developed less favorably than sales. EBITDA margin was −984.2% at the start and −5743.5% at the end. Operating return per unit of revenue declined.

Comparing the endpoints shows a move from −$19.8 million to −$45.3 million. The period ended with a larger loss than it began with.

What the figures show

The indicators point to a weaker financial profile. Key strengths include improving gross profitability. The main areas of concern are a low EBITDA margin, weaker operating efficiency and a weaker final result. The next reporting periods will show whether revenue, margins, and final profitability can strengthen.